See how our MESF & QSC kits support quantitative flow cytometry in cancer research & immunotherapy development.

Enjoy this curated listing of references related to cancer research & immunotherapy development.

Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist.

Telomere Shortening Correlates with Prognostic Score at Diagnosis and Proceeds Rapidly during Progression of Chronic Myeloid Leukemia.

Development of a flow cytometric method for quantification of BCL-2 family members in chronic lymphocytic leukemia and correlation with sensitivity to BCL-2 family inhibitors.

Validation of a quantitative flow cytometer assay for monitoring HER-2/neu expression level in cell-based cancer immunotherapy products.

ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope.

Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs.

Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.

Validation of a flow cytometry-based assay to assess C5aR receptor occupancy on neutrophils and monocytes for use in drug development.

Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome.

Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells.

Comparative Quantitative Analysis of Cluster of Di erentiation 45 Antigen Expression on Lymphocyte Subsets.

A Quantitative Exploration of Surface Antigen Expression in Common B-Cell Malignancies Using Flow Cytometry

CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells.